Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treatment of specific cancers with NLRP3 inhibitors and anti-PD1/PD-L1 antibodies

Methods of treatment of specific cancers with NLRP3 inhibitors and anti-PD1/PD-L1 antibodies

US Patent 12121565 · Granted Oct 22, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Predictive biomarkers for cancer immunotherapy and methods of using same2023
Predictive biomarkers for cancer immunotherapy and methods of using same2023
Composition of matter and methods for alteration of dendritic cell metabolism to2020
Induced activation in dendritic cells2019
Induced activation in dendritic cells2017
Induced activation in dendritic cells2015
Induced activation in dendritic cells2014
Induced activation in dendritic cell2008